These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33374715)

  • 1. Urea-Peptide Hybrids as VEGF-A
    Puszko AK; Sosnowski P; Rignault-Bricard R; Hermine O; Hopfgartner G; Pułka-Ziach K; Lepelletier Y; Misicka A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A
    Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance.
    Puszko AK; Sosnowski P; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Bioorg Med Chem; 2023 Oct; 94():117482. PubMed ID: 37774449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
    Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
    Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A
    Masłowska K; Witkowska E; Tymecka D; Halik PK; Misicka A; Gniazdowska E
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
    Sabki A; Khelifi L; Kameli A; Baali S
    Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine.
    Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M; Nugent MA
    J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
    Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
    Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
    Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
    FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
    FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
    Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
    Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.
    Tymecka D; Lipiński PFJ; Fedorczyk B; Puszko A; Wileńska B; Perret GY; Misicka A
    Peptides; 2017 Aug; 94():25-32. PubMed ID: 28627371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer.
    Neagoe PE; Lemieux C; Sirois MG
    J Biol Chem; 2005 Mar; 280(11):9904-12. PubMed ID: 15637071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
    Jia H; Bagherzadeh A; Hartzoulakis B; Jarvis A; Löhr M; Shaikh S; Aqil R; Cheng L; Tickner M; Esposito D; Harris R; Driscoll PC; Selwood DL; Zachary IC
    J Biol Chem; 2006 May; 281(19):13493-13502. PubMed ID: 16513643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
    Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
    J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method.
    Puszko AK; Sosnowski P; Tymecka D; Raynaud F; Hermine O; Lepelletier Y; Misicka A
    Medchemcomm; 2019 Feb; 10(2):332-340. PubMed ID: 30881620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scandium-44 Radiolabeled Peptide and Peptidomimetic Conjugates Targeting Neuropilin-1 Co-Receptor as Potential Tools for Cancer Diagnosis and Anti-Angiogenic Therapy.
    Masłowska K; Redkiewicz P; Halik PK; Witkowska E; Tymecka D; Walczak R; Choiński J; Misicka A; Gniazdowska E
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.